Clinical Trial Update: Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on a completed Phase 2/3 clinical trial evaluating the efficacy and safety of deferiprone in Parkinson's disease. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

Sponsor: University Hospital, Lille | Conditions: Parkinson's Disease | Phase 2, Phase 3 | Status: COMPLETED